A carregar...
Serum Vascular Endothelial Growth Factor Levels in the IVAN Trial; Relationships with Drug, Dosing, and Systemic Serious Adverse Events
PURPOSE: To describe serum vascular endothelial growth factor (sVEGF) in patients with neovascular age-related macular degeneration (nAMD) receiving anti-VEGF agents and associations between sVEGF and systemic serious adverse events (SSAEs). DESIGN: Exploratory analyses of a randomized controlled tr...
Na minha lista:
| Publicado no: | Ophthalmol Retina |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Published by Elsevier Inc. on behalf of American Academy of Ophthalmology
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6278944/ https://ncbi.nlm.nih.gov/pubmed/30555977 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.oret.2017.05.015 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|